Corteva Reports Fourth Quarter and Full Year 2019 Results and Provides 2020 GuidanceChris LusvardiJan 30, 2020
Novozymes Reports Improvements In Second Half and Quarter Four With The Year Challenged Mainly By Difficult Agricultural MarketsChris LusvardiJan 23, 2020
Marrone Bio Innovations Announces New $23 Million Accounts-Receivable and Inventory-Backed Credit FacilitiesChris LusvardiJan 09, 2020
Yield10 Bioscience Announces Closing of $11.5 Million Equity Offering and Full Exercise of Over-allotment OptionChris LusvardiNov 20, 2019